These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2420730)

  • 21. In vivo effect of isoprinosine on interleukin-2 production, lymphocyte mitogenesis and NK activity in normal and cyclophosphamide immunosuppressed mice.
    Barasoain I; Rejas MT; Ojeda G; Portolés MP; Rojo JM
    Int J Immunopharmacol; 1986; 8(5):509-15. PubMed ID: 2428762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of isoprinosine, levamisole, muramyl dipeptide, and SM1213 on lymphocyte and macrophage function in vitro.
    Hadden JW
    Cancer Treat Rep; 1978 Nov; 62(11):1981-5. PubMed ID: 83192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Restoration of immune responses of aging hamsters by treatment with isoprinosine.
    Tsang KY; Fudenberg HH; Gnagy MJ
    J Clin Invest; 1983 Jun; 71(6):1750-5. PubMed ID: 6190840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro blastogenic responses of peripheral lymphocytes from marmosets to phytohemagglutinin and to autologous lymphocytes transformed by Epstein-Barr virus.
    Sundar SK; Lai PK; Bengall ZH; Cicmanec JL; Goldstein K; Levine PH
    Comp Immunol Microbiol Infect Dis; 1981; 4(1):35-45. PubMed ID: 6269800
    [No Abstract]   [Full Text] [Related]  

  • 25. Cell mediated immunity during infectious mononucleosis to Epstein-Barr virus associated antigens.
    Periman P; Levine PH; Ablashi DV; Royston I
    Int J Cancer; 1977 Oct; 20(4):506-11. PubMed ID: 199544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of human T lymphocyte functions by isoprinosine.
    Rey A; Cupissol D; Thierry C; Esteve C; Serrou B
    Int J Immunopharmacol; 1983; 5(1):99-103. PubMed ID: 6188707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro expansion of Epstein-Barr virus-specific HLA-restricted cytotoxic T cells direct from the blood of infectious mononucleosis patients.
    Strang G; Rickinson AB
    Immunology; 1987 Dec; 62(4):647-54. PubMed ID: 2828228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isoprinosine and Imuthiol, two potentially active compounds in patients with AIDS-related complex symptoms.
    Pompidou A; Delsaux MC; Telvi L; Mace B; Coutance F; Falkenrodt A; Lang JM
    Cancer Res; 1985 Sep; 45(9 Suppl):4671s-4673s. PubMed ID: 2410111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphocyte reactivity in infectious mononucleosis.
    ten Napel CH; The TH
    J Infect Dis; 1980 Jun; 141(6):716-23. PubMed ID: 6248602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IgM antibodies to Epstein-Barr virus-associated membrane antigen in sera of infectious mononucleosis patients.
    Harada M; Sairenji T; Takaki K; Hinuma Y
    Microbiol Immunol; 1980; 24(2):123-32. PubMed ID: 6247623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In-vivo immunomodulation by isoprinosine in patients with the acquired immunodeficiency syndrome and related complexes.
    Grieco MH; Reddy MM; Manvar D; Ahuja KK; Moriarty ML
    Ann Intern Med; 1984 Aug; 101(2):206-7. PubMed ID: 6204566
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacologic immunoenhancement in the elderly: in vitro effects of isoprinosine.
    Delafuente JC; Panush RS
    Clin Immunol Immunopathol; 1988 Jun; 47(3):363-7. PubMed ID: 2453315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of isoprinosine on interleukin 1 and 2 production and on suppressor cell activity in pokeweed mitogen stimulated cultures of B and T cells.
    Hersey P; Bindon C; Bradley M; Hasic E
    Int J Immunopharmacol; 1984; 6(4):321-8. PubMed ID: 6207122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of T- and B-lymphocyte functions by isoprinosine in homosexual subjects with prodromata and in patients with acquired immune deficiency syndrome (AIDS).
    Tsang PH; Tangnavarad K; Solomon S; Bekesi JG
    J Clin Immunol; 1984 Nov; 4(6):469-78. PubMed ID: 6210301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Appearance and some unusual features of Epstein-Barr virus antibody production in infectious mononucleosis and other health disorders.
    Stancek D; Kotuliaková M; Hrúzik J
    Acta Virol; 1977 Jan; 21(1):45-56. PubMed ID: 15437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epstein-Barr virus (EBV) antigen-specific leukocyte migration inhibition (LMI) in infectious mononucleosis (IM). I. Kinetics and response to a membrane protein on EBV-transformed cells.
    Szigeti R; Timar L; Weiland O; Henle W; Henle G; Hennessy K; Kieff E; Sulitzeanu D; Dillner J; Klein G
    Clin Immunol Immunopathol; 1986 Dec; 41(3):342-50. PubMed ID: 3022972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preliminary characterization in mice of the effect of isoprinosine on the immune system.
    Vecchi A; Sironi M; Spreafico F
    Cancer Treat Rep; 1978 Nov; 62(11):1975-9. PubMed ID: 83191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell-mediated immunity, Epstein-Barr virus and nasopharyngeal carcinoma.
    Levine PH; Lamelin JP; Stevens DA
    IARC Sci Publ (1971); 1978; (20):483-94. PubMed ID: 215530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Demonstration of EBNA (Epstein-Barr virus nuclear antigen) antibodies of different immunoglobulin classes.
    Czeglédy J; Gergely L; Váczi L; Szalka A
    Acta Microbiol Acad Sci Hung; 1978; 25(4):237-43. PubMed ID: 224651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluorescence in situ hybridization is superior for monitoring Epstein Barr viral load in infectious mononucleosis patients.
    Cao P; Zhang M; Wang W; Dai Y; Sai B; Sun J; Wang L; Wang F; Li G; Xiang J
    BMC Infect Dis; 2017 May; 17(1):323. PubMed ID: 28468603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.